Natera stock heads into November 5 earnings release

Natera is approaching a scheduled earnings catalyst as the company prepares to release results for the third quarter ended September 30, 2026, after the US market closes on Thursday, November 5. The company announced the timing in an October 29 notice. The Natera investor announcement sets the release and the subsequent call as the next formal update for shareholders.

What Investors Will Hear Next

Natera said the conference call will follow the results release at 4:30 p.m. Eastern Time. The company has also provided a webcast for investors, with a replay available through its investor relations website. The timing puts the financial update outside regular US trading hours, leaving the first full market reaction for the following session.

The quarter is important because Natera's business spans oncology, women's health and organ health, with cell-free DNA and precision-medicine testing at its core. The company's Signatera franchise is part of its oncology offering, while the wider portfolio includes testing for pregnancy-related care and organ-transplant monitoring.

Natera stock traded at 346.20 euros on Lang & Schwarz at 14:14 CET on Thursday, November 5. Investors can follow the real-time quote of Natera stock as the release approaches. The announcement itself does not establish a causal link between the scheduled report and the intraday quote.

Natera stock at a glance

• Company: Natera, Inc.
• ISIN: US6323071042
• Ticker: NTRA
• Trading venue: Lang & Schwarz
• Quote: 346.20 euros on Thursday, November 5, 2026, at 14:14 CET
• Next event: Third-quarter 2026 results and conference call on November 5, 2026

The S&P 500 provides the wider US equity backdrop for the company and its shareholders; see the latest S&P 500 market coverage.

For continuing company-specific coverage, see more news and analyses on Natera stock.